FindTrial
Sign In

Evaluation of efficacy and safety of modified double lamellar keratoplasty in the treatment of corneal perforation

Evaluation of efficacy and safety of modified double lamellar keratoplasty in the treatment of corneal perforation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044371
Enrollment
Unknown
Registered
2021-03-17
Start date
2021-03-17
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal perforation

Interventions

Corneal perforation:Underwent the surgery of MDLK

Sponsors

Department of Ophthalmology, Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who had corneal perforation could not be cured by bandage lens, those who also had iris prolapses and shallow anterior chambers, and underwent the surgery of MDLK with a minimum of six months of postoperative follow-up.

Exclusion criteria

Exclusion criteria: Patients with primary collagen vascular disease, which could cause severe corneal lytic related lesions, such as rheumatoid arthritis, Sjogren's syndrome and Wegener's granulomatosis; those whose diameter of corneal perforation was larger than 2 mm.

Design outcomes

Primary

MeasureTime frame
Best corrected visual acuity;Anterior formation;Corneal graft survival;—

Countries

China

Contacts

Public ContactJianzhang Hu

Department of Ophthalmology, Fujian Medical University Union Hospital

ophhjz@163.com+86 13509321699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026